To determine whether ROS stress might be a potential mechanism for enhancing the cytotoxic effect of cisplatin caused by IDH2 inhibition, we first measured ROS levels in lung cancer cells treated with AGI-6780, cisplatin, or their combination. This evidence concerns the gene IDH2 and lung carcinoma.